Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Shuttle Pharmaceuticals Holdings Inc. SHPH

Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.


Recent & Breaking News (NDAQ:SHPH)

    Shuttle Pharmaceuticals to Present at Lytham Partners Investor Select Conference on January 31

    PR Newswire 7 days ago

    Shuttle Pharmaceuticals to Ring Nasdaq Opening Bell on Wednesday, January 18, 2023

    PR Newswire January 17, 2023

    Shuttle Pharmaceuticals Announces Private Placement of $4.3 Million of Senior Secured Convertible Note and Warrants

    PR Newswire January 12, 2023

    Shuttle Pharmaceuticals Manuscript Published in Cancer Research Communications

    PR Newswire January 10, 2023

    Shuttle Pharmaceuticals Manuscript Published in Cancer Research Communications

    PR Newswire December 6, 2022

    Shuttle Pharmaceuticals Provides Third Quarter 2022 Corporate Update

    PR Newswire November 15, 2022

    Shuttle Pharmaceuticals Engages Theradex Oncology in Preparation for Clinical Study

    PR Newswire November 3, 2022

    Shuttle Pharmaceuticals Appoints Bette Jacobs to its Board of Directors

    PR Newswire November 1, 2022

    Shuttle Pharmaceuticals Enters into Manufacturing Agreement for Ropidoxuridine

    PR Newswire September 20, 2022

    Shuttle Pharmaceuticals Awarded New HDAC Inhibitor Patents for Cancer Treatment

    PR Newswire September 15, 2022

    Shuttle Pharmaceuticals Announces Closing of Initial Public Offering

    PR Newswire September 6, 2022

    Shuttle Pharmaceuticals Commences Trading on Nasdaq Under Ticker Symbol "SHPH"

    PR Newswire August 31, 2022

    Shuttle Pharmaceuticals Announces Pricing of Initial Public Offering

    PR Newswire August 30, 2022